
    
      PHASE I:

      3 cycles of Brentuximab Vedotin ICE every 3 weeks and one cycle of Brentuximab Vedotin alone
      at the doses described below.

      Cohorts of between three and six evaluable patients will be recruited at each dose level.

      Dose escalation rules:

      Treat 3 patients at level K

        1. If 0 patients experience dose-limiting toxicity (DLT), escalate to dose K+1

        2. If 2 or more patients experience DLT, de-escalate to level K-1

        3. If 1 patient experiences DLT, treat 3 more patients at dose level K A. If 1 of 6
           experiences DLT, escalate to dose level K+1 B. If 2 or more of 6 experiences DLT,
           de-escalate to level K-1 Dose escalation will begin at level K.

      Level K:

      Brentuximab Vedotin: 1.2 mg/kg (cycle 1-3), 1.8 mg/kg (cycle 4) ICE (cycle 1-3): Etoposide
      100 mg/m² (day1 to 3); Carboplatine max 800mg (day 2); Ifosfamide + Mesna 5 g/m² (day 2)

      Level K -1:

      Brentuximab Vedotin: 0.8 mg/kg (cycle 1-3), 1.8 mg/kg (cycle 4) ICE (cycle 1-3): Etoposide
      100 mg/m² (day1 to 3); Carboplatine max 800mg (day 2); Ifosfamide + Mesna 5 g/m² (day 2)

      Level K +1:

      Brentuximab Vedotin: 1.8 mg/kg (cycle 1-3), 1.8 mg/kg (cycle 4) ICE (cycle 1-3): Etoposide
      100 mg/m² (day1 to 3); Carboplatine max 800mg (day 2); Ifosfamide + Mesna 5 g/m² (day 2)

      Dose finding rule:

      Provisional dose levels are listed in previous tables. Dose-escalation will continue until
      Maximal Tolerated Dose (MTD) or Recommended Phase 2 Dose (RP2D) is reached or the full doses
      of BV and ICE are delivered without DLT

      PHASE II:

      3 cycles of Brentuximab Vedotin + ICE every 3 weeks and one cycle Brentuximab Vedotin alone.

      The recommended dose of BV and ICE will be determined by the phase I Brentuximab Vedotin: MTD
      mg/kg (cycle 1-3), 1.8 mg/kg (cycle 4) ICE (cycle 1-3): Etoposide 100 mg/m² (day1 to 3);
      Carboplatine max 800mg (day 2); Ifosfamide + Mesna 5 g/m² (day 2) The recommended dose of BV
      and ICE will be determined by the phase I.
    
  